The European Union, in a strategic move leveraging the anti-science rhetoric of the Trump administration, is negotiating a new medicines deal. This agreement includes a ten-year protection period for patents, with potential extensions for significant innovations, addressing unmet medical needs, conducting clinical trials, and improving accessibility across member states. These measures aim to incentivize pharmaceutical […]
